Literature DB >> 6778220

Utilization of leucine by working rat heart.

K Ichihara, J R Neely, D L Siehl, H E Morgan.   

Abstract

Leucine provided substrate to partially support mechanical activity of working rat hearts; the beneficial effect on peak systolic pressure development was more marked as leucine concentration was increased to 10 mM. In Langendorff preparations that had been exposed to 5 mM [U-14C]leucine, the imposition of cardiac work was accompanied by a threefold increase in the rate of 14CO2 production within the first 30 s; however, the rate decreased 40% in the next 10 min. This transient acceleration of 14CO2 production was not observed when [1-14C]leucine was provided and appeared to be due to oxidation of a tissue pool of radioactive intermediates that was present after 10 min of Langendorff perfusion. Over a period of 1 h, oxidation of either [U-14C]- or [1-14C]leucine increased 25-40% in working compared to Langendorff preparations that were supplied 5 mM leucine and 11 mM glucose. In working hearts that were supplied a substrate and hormone mixture that simulated normal plasma and 1 mM leucine, a concentration found in the plasma of diabetic but not normal rats, leucine oxidation was accelerated 73% by work but amounted to only 3.3% of oxygen consumption.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778220     DOI: 10.1152/ajpendo.1980.239.6.E430

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Six blind men explore an elephant: aspects of fuel metabolism and the control of tricarboxylic acid cycle activity in heart muscle.

Authors:  H Taegtmeyer
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

2.  Use of the perfused rat heart to study cardiac metabolism: retrospective and prospective views.

Authors:  J R Williamson; K Kobayashi
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

3.  L-leucine transport in rat heart under normal conditions and effects of a simulated hypoxia.

Authors:  N King; M S Suleiman
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

4.  Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts.

Authors:  Giulio Agnetti; Nina Kaludercic; Lesley A Kane; Steven T Elliott; Yurong Guo; Khalid Chakir; Daya Samantapudi; Nazareno Paolocci; Gordon F Tomaselli; David A Kass; Jennifer E Van Eyk
Journal:  Circ Cardiovasc Genet       Date:  2009-11-17

5.  Myocardial oxidative metabolism and protein synthesis during mechanical circulatory support by extracorporeal membrane oxygenation.

Authors:  Colleen M O'Kelly Priddy; Masaki Kajimoto; Dolena R Ledee; Bertrand Bouchard; Nancy Isern; Aaron K Olson; Christine Des Rosiers; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

6.  On the inability of ketone bodies to serve as the only energy providing substrate for rat heart at physiological work load.

Authors:  H Taegtmeyer
Journal:  Basic Res Cardiol       Date:  1983 Jul-Aug       Impact factor: 17.165

7.  Role of activation of myocardial branched-chain 2-oxo acid dehydrogenase complex in the regulation of leucine decarboxylation during cardiac work in vitro.

Authors:  E Hildebrandt; M S Olson
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

8.  Regulation of myocardial amino acid balance in the conscious dog.

Authors:  R G Schwartz; E J Barrett; C K Francis; R Jacob; B L Zaret
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

9.  Myocardial protein turnover in patients with coronary artery disease. Effect of branched chain amino acid infusion.

Authors:  L H Young; P H McNulty; C Morgan; L I Deckelbaum; B L Zaret; E J Barrett
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

10.  Circadian rhythms in cardiac metabolic flexibility.

Authors:  Martin E Young; Mary N Latimer
Journal:  Chronobiol Int       Date:  2021-06-23       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.